DarinErikOlsonMDPhD

Endocrinology • Edwards, CO

Diabetes, Lipid Metabolism

Endocrinologist

Join to view full profile

Dr. Olson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Olson's full profile

Already have an account?

Office
322 Beard Creek Rd
Ste 1300
Edwards, CO 81632
Phone+1 970-926-6340

Fax+1 970-926-6348

Education & Training

Emory University School of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 2000 - 2003
Emory University School of MedicineResidency, Internal Medicine, 1997 - 2000
Boston University School of MedicineClass of 1997

Certifications & Licensure

CO State Medical License 2021 - 2025
GA State Medical License 1999 - 2023
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Clinical Trials

Basal Bolus Insulin Versus SSRI in Type 2 Diabetes Undergoing General Surgery Start of enrollment: 2007 Dec 01
Completed
Phase 4
Basal Bolus Versus Basal Insulin in Type 2 Diabetes Mellitus (T2DM) Start of enrollment: 2010 Jan 01
Completed
Phase 4
A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes Start of enrollment: 2013 May 01
Completed
Phase 3
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes Start of enrollment: 2014 Feb 01
Completed
Phase 3
ADA Linagliptin in Long Term Care Start of enrollment: 2014 Apr 25
Completed
Phase 4
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) Start of enrollment: 2017 Mar 23
Terminated
Phase 3
A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men Start of enrollment: 2018 May 03
Completed
Phase 4
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults Start of enrollment: 2020 Sep 01
Recruiting
Phase 4
Join now to see all

Publications & Presentations

PubMed

161 citations
American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.
Lawrence Blonde, Guillermo E Umpierrez, S Sethu Reddy, Janet B McGill, Sarah L Berga
Endocrine Practice. 2022-10-01
1 citations
In type 1 diabetes, real-time vs. intermittently scanned continuous glucose monitoring improved glycemic control.
Darin E. Olson
Annals of Internal Medicine. 2021-10-01
12 citations
Association of Baseline Characteristics With Insulin Sensitivity and β-Cell Function in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRA...
Neda Rasouli, Naji Younes, Kristina M. Utzschneider, Silvio E. Inzucchi, Ashok Balasubramanyam
Diabetes Care. 2021-02-01

Lectures

Participation in a Lifestyle Change Program Is Associated with Reduced Incidence of Cardiovascular Disease in a Large National Health Care System
Atlanta, GA - 6/16/2014

Press Mentions

How to Best Protect People with Diabetes from the Impact of SARS-CoV-2: Report of the International COVID-19 and Diabetes SummitJanuary 21st, 2021

Professional Memberships

American Diabetes Association - ADA
Member
Endocrine Society - ENDO
Member